35 /100
MEDIUM RISK
Score updated May 30, 2026

CLLS — Cellectis S.A. Dilution Risk Tracker

Track CLLS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CLLS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
65
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
24%
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
💰 Capital Raise 15%
• Under 12 months cash (8mo)
🔔 Track CLLS — Get forecast alerts →

💹 Market Data

Market Cap$354.15M
Shares Outstanding72.61M
Float64.64M
Cash$34.84M
Debt$32.20M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 25.8% shares (2025Q4 vs prior)
35 institutional holders · 10.55M shares
#1 B Group, Inc. 3.28M shares
#2 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 3.18M shares
#3 Long Focus Capital Management, LLC 2.79M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest337.4K
Days to Cover15.3
% of Float0.5%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track CLLS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CLLS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CLLS
📊 CLLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CLLS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.